Dr. Boddu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar St
New Haven, CT 06510Phone+1 832-396-4414
Education & Training
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2013 - 2016
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 2013 - 2016
Osmania Medical College NTR UHSClass of 2012
Certifications & Licensure
CT State Medical License 2018 - 2025
CA State Medical License 2015 - 2019
TX State Medical License 2016 - 2019
IL State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 338 citationsEfficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.Naval Daver, Guillermo Garcia-Manero, Sreyashi Basu, Prajwal Boddu, Mansour Alfayez
Cancer Discovery. 2019-03-01 - 28 citationsInitial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.Prajwal Boddu, Gautam Borthakur, Mythili Koneru, Xuelin Huang, Kiran Naqvi
Frontiers in Oncology. 2018-09-24 - 10 citationsSLE and Non-Hodgkin's Lymphoma: A Case Series and Review of the Literature.Prajwal Boddu, Chandrahasa Annem, Winston Sequeira
Case Reports in Rheumatology. 2017-03-27
Abstracts/Posters
- Analysis of Factors Predictive of Risk of Transformation and Time to Transformation in Patients (pts) with Mantle Cell Lymphoma _ Cohort Study of 369 PatientsPrajwal Boddu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Diverse Landscape of TET2 Variants in MDS and AML2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Clinical and Genomic Characteristics in De Novo Blastoid/Pleomorphic (dnMCL) and Transformed Blastoid/Pleomorphic (t-MCL) Mantle Cell Lymphoma (MCL) in the Ibrutinib E...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Validation of the ELN-2017 risk classification in younger adult patients (pts) with AML.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
